Comparing the Opportunities for New and "At-Risk" Investigators R01 and ReWARD R01

Learn more about each program:

Use the table below to determine which program best aligns with your proposal.

 Opportunities for New and "At-Risk" Investigators R01ReWARD R01
 
PurposeTo support independent research projects from a diverse cohort of New Investigators and At-Risk Investigators.To support the research of scientists who are making a significant contribution to Diversity, Equity, Inclusion, and Accessibility (DEIA)
PD(s)/PI(s)New Investigators (including Early Stage Investigators) or At Risk Investigators from diverse backgrounds, including those from groups underrepresented in the health-related sciences (e.g., see NOT-OD-20-031, Notice of NIH’s Interest in Diversity)Has no NIH Research Project Grant (RPG) funding at time of award and is making significant, sustained, and impactful, contributions to DEIA
Review locusCSR standing study sectionsCSR Special Emphasis Panel
Support forResearch in areas related to the programmatic interests of NINDSResearch in areas related to the programmatic interests of NINDS and DEIA activities focused on enhancing diversity in the US biomedical research enterprise
Clinical trials allowed?Only BESH or mechanistic clinical trials allowedNo trials of safety, tolerability, clinical efficacy, effectiveness, clinical management, and/or implementation of interventions.
Due datesStandard R01 due datesStandard R01 due dates